Skip to main content
Clinical Trials/NCT04336033
NCT04336033
Recruiting
Not Applicable

Validation and Evaluation of a Newly Developed Mobile Diet App for Enhancing Dietary Adherence for Patients With Chronic Kidney Disease (CKD)

Universiti Putra Malaysia1 site in 1 country90 target enrollmentFebruary 15, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Kidney Diseases
Sponsor
Universiti Putra Malaysia
Enrollment
90
Locations
1
Primary Endpoint
Serum Kidney Function Test
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

A 12-week, prospective, multicenter, open-label pilot randomized controlled trial (RCT) will be carried out to determine the feasibility, acceptability and potential clinical efficacy of a newly developed mobile diet app among CKD populations at different stages in Malaysia. Participants will be randomly assigned into either (i) intervention group (mobile diet app) or (ii) control group (dietary counseling using conventional pamphlet).

Detailed Description

General Objective: To evaluate a newly developed mobile diet app in enhancing dietary adherence for patients with chronic kidney disease. Specific Objectives: 1. To validate the newly developed mobile diet app for patient with chronic kidney disease. 2. To determine the feasibility and acceptability of this newly developed mobile diet app among patients with chronic kidney disease. 3. To evaluate the preliminary efficacy of the newly developed mobile diet app in enhancing dietary adherence in patients with chronic kidney disease

Registry
clinicaltrials.gov
Start Date
February 15, 2023
End Date
April 30, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jazlina binti Syahrul

Principle Investigator [Dietitian]

Universiti Putra Malaysia

Eligibility Criteria

Inclusion Criteria

  • Clinically diagnosed CKD / eGFR \< 60 ml/min/1.73m2 for ≥ 3 months (only applicable to pre-dialysis patients.
  • Undergone maintenance dialysis for at least 3 months (only applicable to dialysis patients)
  • Possessing smartphone and is willing to use health app
  • Alert and oriented
  • At least 18 years of age

Exclusion Criteria

  • Inability to use the smartphone app (e.g. due to vision problems)
  • Hard to comply with home monitoring (e.g. suffering from anxiety or depression)
  • Refuse to comply with dietary prescription
  • Patients who participate in other study at the same time
  • Patients who have participated in another research study involving an investigational product in the past 12 weeks preceding enrollment.
  • Planning for kidney transplant over the study duration.
  • Female patients who are pregnant, lactating or planning a pregnancy during the course of the trial.
  • Participants who are receiving nutritional support (i.e. enteral and intra-venous route).
  • Participants who are currently receiving active treatment for cancer

Outcomes

Primary Outcomes

Serum Kidney Function Test

Time Frame: 3 months

Routine collected biochemical results from the patients' medical records: - urea, sodium, chloride, potassium and creatinine will be measured in mmol/L

Serum Blood Sugar Profile

Time Frame: 2 weeks

Routine collected biochemical results from the patients' medical records and blood sugar (mmol/L) also will be recorded if patient had done self-monitoring blood glucose at home

Glomerular Filtration Rate (eGFR)

Time Frame: 3 months

Estimated glomerular filtration rate (eGFR) will be recorded in of mL/min/1.73m2.

Serum Hemoglobin A1C Test

Time Frame: 3 months

Routine collected biochemical results from the patients' medical records for HbA1C (%)

Albuminuria

Time Frame: 12 weeks

Routine collected urine analysis to measure urine albumin (mg) if there is presence of albumin or protein

Dietary History

Time Frame: 6 weeks

Three-day diet records (3DDR) : 2 days weekdays + 1 weekend / dialysis and non-dialysis day. Measured unit is in kilocalories (kcal)/day

Dietary Adherence

Time Frame: 6 weeks

End Stage Renal Disease Adherence Questionnaire (ESRD-AQ): - validated questionnaires which consists of 4 subscales pertaining dialysis, medication, dietary and fluid adherences. Patients will need to rate their fluid and dietary adherence on a numerical rating scale which composed of 0% (None of the time) to 100% (All of the time).

Secondary Outcomes

  • Acceptability: User Acceptance test (UAT)(12 weeks)
  • Nutrition Literacy(12 weeks)
  • Dietary Knowledge(12 weeks)
  • Feasibility of the app: interview(12 weeks)
  • Users Satisfaction: Likert scale(12 weeks)
  • Health Behaviour(12 weeks)
  • Nutritional Status(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials